The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Friday, January 24, 2014
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs CD34 ...
Miltenyi Biotec Receives FDA Approval for CliniMACSA CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia CAMBRIDGE, Mass.
No comments:
Post a Comment